Commissioner Nominee Reveals More Complicated Finances Ahead Of Second Confirmation Process

Robert Califf. (Alamy)
Robert Califf's financial disclosure report indicates his IRA includes holdings in several pharma companies. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA

More from Agency Leadership